Macrophage accumulation in murine ascites tumors. I. Cytoxan-induced dominance of macrophages over tumor cells and the anti-tumor effect of endotoxin
- PMID: 6774024
Macrophage accumulation in murine ascites tumors. I. Cytoxan-induced dominance of macrophages over tumor cells and the anti-tumor effect of endotoxin
Abstract
The host cellular response to i.p. growth of the SA-1 spindle cell sarcoma was studied in semisyngeneic AB6F1 hybrid mice. At progressive stages of tumor growth mice were sacrificed, their ascites were collected, and changes in the numbers of tumor cells, macrophages, lymphocytes, and granulocytes were determined. It was found that macrophages were the predominant host cell that accumulated locally in response to tumor growth. Cytoxan treatment caused a 90% reduction in tumor cells without affecting the accumulation of macrophages. Six days after treatment with cytoxan, macrophages exceeded all other cell types present in the peritoneal cavity and outnumbered tumor cells by 20:1. However, in spite of this macrophage dominance, the tumor cells ultimately regrew to kill the host. Ascites tumors could be completely regressed, however, by following cytoxan treatment with an appropriately timed intratumor injection of endotoxin. The relatively long delay before endotoxin caused the tumor to regress suggests that endotoxin acted by stimulating the generation of anti-tumor immunity, rather than by directly augmenting the tumoricidal activity of macrophages.
Similar articles
-
Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.Cancer Res. 2002 Sep 1;62(17):5069-75. Cancer Res. 2002. PMID: 12208763
-
Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.Am J Pathol. 1980 Jun;99(3):667-84. Am J Pathol. 1980. PMID: 7386598 Free PMC article.
-
The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.J Immunol. 1982 Jun;128(6):2816-23. J Immunol. 1982. PMID: 6804569
-
The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.J Immunol. 1985 Jun;134(6):4255-60. J Immunol. 1985. PMID: 3872913
-
Concurrent depression of tumor macrophage infiltration and systemic inflammation by progressive cancer growth.Cancer Res. 1978 Oct;38(10):3453-9. Cancer Res. 1978. PMID: 99232
Cited by
-
Tumor reductive therapies and antitumor immunity.Oncotarget. 2017 Jun 14;8(33):55736-55749. doi: 10.18632/oncotarget.18469. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903456 Free PMC article. Review.
-
Enhanced T-cell-independent antitumor effect of cyclophosphamide combined with anti-CD40 mAb and CpG in mice.J Immunother. 2011 Jan;34(1):76-84. doi: 10.1097/CJI.0b013e318200b28a. J Immunother. 2011. PMID: 21150715 Free PMC article.
-
Effect of lipopolysaccharides, lipid A and interferon on the cell-mediated cytotoxicity of human leukocytes against K-562 tumor cells.Infection. 1984 Sep-Oct;12(5):322-7. doi: 10.1007/BF01651145. Infection. 1984. PMID: 6392103
-
T-cell-independent antitumor effects of CD40 ligation.Int Rev Immunol. 2012 Aug;31(4):267-78. doi: 10.3109/08830185.2012.698337. Int Rev Immunol. 2012. PMID: 22804571 Free PMC article. Review.
-
Cytocidal and toxic effect of various cytostatic drugs on three ascites tumors of the mouse.J Cancer Res Clin Oncol. 1987;113(3):216-22. doi: 10.1007/BF00396376. J Cancer Res Clin Oncol. 1987. PMID: 3584212 Free PMC article.